Indian Firm Received Tramadol License
From Business Standard:Ranbaxy Laboratories has announced a strategic in-licensing agreement for the Indian market, with Ethypharm LL India, a wholly-owned subsidiary of a French drug delivery firm, for the Novel Drug Delivery System (NDDS) analgesic, Tramadol 50 mg Flashtab.
According to an official release issued by Ranbaxy to the BSE today, the product will be supplied from Ethypharm's manufacturing facility near Mumbai, and marketed and distributed by Ranbaxy under the brand name 'Trambax'.
"The introduction of Trambax (Tramadol Flashtab®) Tablets is part of Ranbaxy's strategy to provide world-class products with NDDS technology to doctors in India bringing rapid pain relief to their patients. This will further strengthen our portfolio in the pain management segment,"Sanjeev I Dani, regional director (India and Middle East) of Ranbaxy, said.
Tramadol for pain relief is a drug of choice for severe to moderately severe pain in trauma cases and is currently one of the four most commonly prescribed analgesics worldwide. It is also used as an adjunct therapy in the treatment of cancer patients, the release said.
posted by nattietodd @ 8:43 AM
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home